+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Immunoglobulin"

From
HYQVIA - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

HYQVIA - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 30 Pages
  • Global
From
From
From
From
Allergic Rhinitis: Epidemiology Forecast to 2028 - Product Thumbnail Image

Allergic Rhinitis: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 44 Pages
  • Global
From
Loading Indicator

The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production. The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios. Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more